跳至主要内容
临床试验/JPRN-UMIN000025109
JPRN-UMIN000025109已完成未知

A phase II study of definitive chemoradiation therapy using docetaxel, nedaplatin, and 5-fluorouracil with modified dose radiation (mDNF-R) followed by S-1 maintenance therapy and salvage therapy for patients with clinical stage IB-IIIC (non-T4) esophageal carcinoma - A phase II study of mDNF-R followed by S-1 maintenance therapy and salvage therapy for patients with esophageal carcinoma

Sapporo Medical University School of Medicine, Department of Medical Oncology0 个研究点目标入组 24 人开始时间: 2016年12月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) prior chemotherapy and radiotherapy (2) history of drug hypersensitivity (3) contraindication for docetaxel, nedaplatin , 5-FU, or G-CSF (4) active concomitant malignancy. (5) severe heart disease (6) severe diabetes mellitus, severe hypertension, active infection (7) interstitial pneumonia or pulmonary fibrosis (8) pregnant or lactating females (9) high fever (10) the investigator considers not suitable for the study

研究者

发起方
Sapporo Medical University School of Medicine, Department of Medical Oncology

相似试验